Genetic Determinants of Kidney Disease in People of African Ancestry With HIV
NCT05685810 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3029
Last updated 2025-09-03
Summary
Black ethnicity is a major risk factor for chronic kidney disease \[CKD\] in people with HIV infection, suggesting that genetic factors are an important determinant of kidney disease progression in this population. The Gen-Africa study was established in 2018 to allow the study of genetic and clinical risk factors for CKD in people with HIV in the UK. Just over 3000 people across 15 sites were enrolled between May 2018 and January 2020. Demographic and clinical information was collected, and biological samples (buffy coats, plasma and urine) obtained. Cross-sectional analyses have revealed that participants of West-African ancestry are at higher risk of CKD and end-stage kidney disease \[ESKD\], and that genetic variants in the apolipoprotein L1 (APOL1) gene and sickle cell trait (SCT) are predictors of CKD and ESKD. The pathogenesis of APOL1- and SCT-associated CKD is incompletely understood, and additional, longitudinal data will be collected to improve understanding of the contribution of demographic, traditional CKD (diabetes, hypertension, obesity/metabolic syndrome, cardiovascular disease) and HIV (immuno-virological and hepatitis B/C co-infection status, antiretroviral medications) risk factors as well as additional genetic and epigenetic markers.
Conditions
- HIV Nephropathy
- Kidney Injury
- Kidney Diseases
- Diabetes Mellitus
- Obesity
- Cardiovascular Diseases
- Genetic Predisposition to Disease
Sponsors & Collaborators
-
Guy's and St Thomas' NHS Foundation Trust
collaborator OTHER -
Lewisham and Greenwich NHS Trust
collaborator OTHER_GOV -
Royal Free Hospital NHS Foundation Trust
collaborator OTHER -
Central and North West London NHS Foundation Trust
collaborator OTHER -
Barts & The London NHS Trust
collaborator OTHER -
Chelsea and Westminster NHS Foundation Trust
collaborator OTHER -
Imperial College Healthcare NHS Trust
collaborator OTHER -
North Middlesex University Hospital NHS Trust
collaborator OTHER_GOV -
Brighton and Sussex University Hospitals NHS Trust
collaborator OTHER -
The Leeds Teaching Hospitals NHS Trust
collaborator OTHER -
Manchester University NHS Foundation Trust
collaborator OTHER_GOV -
Newcastle-upon-Tyne Hospitals NHS Trust
collaborator OTHER -
South Tees Hospitals NHS Foundation Trust
collaborator OTHER -
Africa Advocacy Foundation
collaborator UNKNOWN -
Vanderbilt University
collaborator OTHER -
University of Cape Town
collaborator OTHER - collaborator OTHER
- collaborator OTHER_GOV
-
British HIV Association
collaborator UNKNOWN - collaborator INDUSTRY
-
St George's Healthcare NHS Trust
collaborator OTHER -
Guy's & St Thomas' Charity
collaborator OTHER -
King's College Hospital NHS Trust
lead OTHER
Principal Investigators
-
Frank A Post · King's College Hospital NHS Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-01
- Primary Completion
- 2020-01-31
- Completion
- 2030-01-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Analysis of Genetic Factors Which May Influence the Course of HIV Infection
NCT00159068 ·Status: COMPLETED
-
A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
NCT00069004 ·Status: COMPLETED
-
Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Follow-up
NCT01667068 ·Status: COMPLETED
-
Nonalcoholic Fatty Liver Disease in HIV Database
NCT05023044 ·Status: ACTIVE_NOT_RECRUITING
-
The Cleveland Cardiometabolic Cohort
NCT03059121 ·Status: COMPLETED
-
HIV-1 Resistance at Screening for HIV Prevention Studies
NCT01204814 ·Status: COMPLETED
-
Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa
NCT00006298 ·Status: COMPLETED
-
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
NCT06113003 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
NCT00575939 ·Status: COMPLETED
-
Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy
NCT00009256 ·Status: COMPLETED
-
Cardiovascular Risk Evaluation and Antiretrovirals in HIV
NCT01015092 ·Status: COMPLETED
-
Examining Factors That May Influence Resistance to HIV-1 Infection
NCT00351442 ·Status: COMPLETED
-
Geriatric HIV Cohort in Sub Sahara Africa
NCT04313699 ·Status: UNKNOWN
-
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
NCT04795219 ·Status: ACTIVE_NOT_RECRUITING
-
Can Undetectable (Viral Load) = Untransmissible (Virus) Change the Life Course of Adolescents Living in Africa
NCT05278559 ·Status: UNKNOWN
-
Aging With HIV and Neurocognitive Decline, a Follow-up Study
NCT05385588 ·Status: COMPLETED ·Phase: NA
-
Renal Function Assessment in HIV Patient
NCT00821847 ·Status: COMPLETED
-
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
NCT05510908 ·Status: COMPLETED
-
HIV and Cardiovascular Risk
NCT00465426 ·Status: COMPLETED
-
Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
NCT02060162 ·Status: COMPLETED
-
Examining the Link Between Heart Disease and HIV Infection in Women
NCT00312468 ·Status: COMPLETED
-
Evaluation and Monitoring of Patients With HIV Infectionn
NCT00557570 ·Status: COMPLETED
-
Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth
NCT00107029 ·Status: COMPLETED
-
Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV
NCT03296202 ·Status: RECRUITING
-
Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa
NCT02192658 ·Status: COMPLETED